Hartenberg Holding acquired Reprofit and GynCentrum
May 26, 2014
Hartenberg Holding has acquired majority shareholding in the leader in the segment of private gynecological clinics and reproductive medicine – Reprofit International s.r.o. and GynCentrum s.r.o. The acquisition is done via Hartenberg’s daughter company – FutureLife a.s.
“We consider the healthcare sector interesting and we would like to be a responsible and long-term strategic partner. Reprofit and GynCentrum have a great reputation in the industry and are led by teams of top professionals,” said Jozef Janov, Managing Partner of Hartenberg.
“Thanks to the long-term investor with sufficient capital, we will be able to continue further development of the clinics and build a leading player in the Czech Republic,” said MUDr. Ladislav Zgabur, co-shareholder of FutureLife that will cover both investments. MUDr. Zgabur initiated the project and continues to act as an industry expert for FutureLife.
Reprofit International based in Brno is the largest private clinic specializing in infertility treatment in the Czech Republic.
“Reprofit is the fastest growing clinic specializing in infertility treatment in the Czech Republic and since 2011, we are the biggest clinic in terms of number of patients. By entry of a new strategic partner we will also receive support for the applied research and other development projects, which will help us to strengthen our leading position in infertility treatment”, said MUDr. Marek Koudelka, Medical Director of the clinic.
GynCentrum, based in Prague, is a private medical facility providing medical care in gynecology, plastic and cosmetic surgery, plastic and cosmetic gynecology, counseling and physical examining of infertile couples – IVF, internal medicine, obesitology and surgical treatment of varicose veins.
“We welcome the arrival of new investors and look forward to it. Thanks to them we can continue to develop the clinic and strengthen its position as the largest private gynecological clinic in Prague,” said MUDr. Petr Pícha, Chief Physician of Gyncentrum.
Reprofit was founded in 2006 as the first clinic in the Czech Republic with team specialized in infertility treatment with the use of donor eggs and was subsequently expanded to include all modern methods of infertility treatment. In addition to assisted reproduction center, the clinic also provides general gynecological care and medical care during pregnancy as a part of their gynecological section with ambulances, as well as its center of oncological prevention and a modern operating room. Currently it belongs among the largest centers of a similar type in the Czech Republic. Its uniqueness is particularly due to its individual expertise and highly specialized activities.
In 2013, Reprofit clinic performed 3 700 treatment cycles on 2 500 patients. 1 100 treatment cycles were performed via egg donation, which is more than 1/4 of all such cycles performed in the Czech Republic according to data from National Register of Assisted Reproduction. The clinic is popular not only in the Czech Republic but also abroad, whereby 68% of all patients comes from abroad.
GynCentrum, a private medical facility in Prague – Hloubětín, founded in 1992, provides medical care in gynecology, plastic and cosmetic surgery, plastic and cosmetic gynecology, counseling and screening of infertile couples – IVF, internal medicine, obesitology and surgical treatment of varicose veins.
GynCentrum is equipped with superior diagnostic and surgical technology, allowing early prevention and effective treatment. Operating rooms with modern pressurized air-conditioning and quality anesthesia devices ensures a very gentle approach to patients and minimal time spent in hospital.
GynCentrum with its individual approach to each patient, whether it is the provision of health care, the attention of the medical staff, or, if necessary, provision of additional expert examination and cooperation of specialists from various medical fields, meets the high demands placed on this type of medical facility.
FutureLife aims to create a healthcare holding in the Czech and Slovak Republic. Shareholders of FutureLife are Hartenberg Holding, MUDr. Zgabur (founder) and management.
Hartenberg Holding is a company focused on investments in assets in the Central European Region, primarily Czech Republic, Slovakia and Poland. Equity commitments from the founders reach 200 million EUR.
We prefer to be a long-term investor in companies we acquire, in some cases we may stay “forever”.
Shareholders of Hartenberg Holding are Mr. Andrej Babiš and Mr. Jozef Janov.